What is the ticker symbol for Yumanity Therapeutics?

Yumanity Therapeutics trades under the ticker YMTX on NASDAQ.

What sector does Yumanity Therapeutics operate in?

Yumanity Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze YMTX in a portfolio?

PortView shows YMTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Yumanity Therapeutics (YMTX) Stock Analysis

NASDAQHealthcareBiotechnology

$1.89+8.62%

1-year price historyRange $0.97 – $3.53

52-week range$1.89

$0.95$3.37

Track YMTX in your portfolio for free · Portfolio tracker

What Yumanity Therapeutics does

Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.

Key metrics

Market cap

$15.72M

P/E (TTM)

-0.45

EPS (TTM)

$-4.24

Beta

0.00

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.77

200-day avg

$1.59

52-week high

$3.37

52-week low

$0.95

ETFs linked to YMTX

Broad-market and Healthcare sector ETFs an investor holding Yumanity Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how YMTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze YMTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Yumanity Therapeutics?: Yumanity Therapeutics trades under the ticker YMTX on NASDAQ.
Which exchange is YMTX listed on?: YMTX is listed on NASDAQ.
What sector does Yumanity Therapeutics operate in?: Yumanity Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze YMTX in a portfolio?: PortView shows YMTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.